NewCardio Announces Master Services Agreement With Dedicated Phase I
... QTinno(TM) software solution in all TQT studies
where fully automated readings are obtained.
... studies, becoming a turnkey provider of these studies
to its customers.
Jason Bonanza, ... our existing solutions, we can deliver TQT/QTc studies
for upload to the FDA digital ECG warehouse with ...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
... H1N1 VLP vaccine to support human clinical studies
and stands ready to assist with additional public ... initiation, rate and progress of its preclinical studies
and clinical trials and other research and ... trial results; even if the data from preclinical studies
or clinical trials is positive, the product may ...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... approval is based on four acute symptom control studies
and a longer-term maintenance study that compared ... Each of the three additional acute treatment studies
involving INVEGA(R) SUSTENNA(TM) met its ... like INVEGA ((R)) SUSTENNA(TM) in clinical studies
for psychosis caused by dementia (memory ...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
... RG7128 (formerly known as R7128). In vitro studies
of PSI-7851 have not shown evidence of any ... is also in INFORM studies, the first series of studies
designed to assess the potential of combinations ... Copegus(R) to treat chronic HCV. These clinical studies
are being conducted through a strategic ...
Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
... on HRT, dermatologists argue that scientific studies
of estrogen do not show definitive improvements ... of California at Davis in Sacramento, reviewed studies
that demonstrate mixed results when examining ... on HRT noticing an improvement in their skin, studies
were conducted to determine if these results ...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
... neuroendocrine and lung cancers. Phase III studies
of IMC-A12 are expected to begin in either late ... study in ovarian cancer, and additional Phase II studies
in other tumor types are planned;
Phase II studies
of IMC-1121B have been expanded to include ...
July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
... a doctor's supervision.
Vitamin C: studies
have shown that eating food high in vitamin C can ... supplements provide the same benefits.
have shown that vitamin C supplements, taken with ... risk of some cancers and heart disease. Recent studies
suggest that vitamin E supplements don't provide ...
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
... today announced positive results from two Phase 3 studies
of intravenous (i.v.) peramivir in patients with seasonal influenza. The studies
were sponsored by BioCryst's partner Shionogi ... in Korea, co-conducted the portion of the studies
In patients with ...
Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference
... DHA Drug Trials
Results from two large studies
using DHA, an omega 3 fatty acid, were reported ... and learning. The results need confirmation. Both studies
used Martek's algal DHA.
These two studies
-- and other recent Alzheimer's therapy trials -- ...
Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline
... July 12 /PRNewswire/ -- Results from two large studies
using DHA, an omega 3 fatty acid, were reported ... on "age related cognitive decline" (ARCD). Both studies
used Martek's algal DHA.
The results of ... standard scientific practice.
"These two studies
- and other recent Alzheimer's therapy trials - ...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
... (FDA) based on evaluations from the ASCEND studies
[Assessing the Safety and Clinical Efficacy of a ... g/day 800 mg tablet)].
In six-week clinical studies
of moderately active UC flares, Asacol HD at 4.8 ...
The primary endpoint of the ASCEND II and III studies
was overall improvement at six weeks, which was ...
Number of Patients With Dementia on the Rise
... who reach 85 will become demented, according to studies
conducted by investigators at Rush Medical Center ... trials for medications that treat Alzheimer's. studies
with glucose are being supplemented by PET scans ... with my family history," Sabin says. "I felt studies
I was participating in would help other people so ...
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
... Center of Dallas, are translating these animal studies
of the protective effects of rapid estrogen ... from the UNT Health Science Center to these studies
in human subjects. If we can administer these ... the brain and increase survival."
in animals found that rapidly administering a ...
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
... exclusivity. Eisai plans to complete the ongoing studies
to provide important information on this ... backed by numerous well-controlled clinical studies
of AD in all stages and settings among thousands ... cramps or loss of appetite or may feel tired. In studies
these were usually mild and temporary.
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
presented at the IEC further reinforce the ... patients enrolled in the three pivotal
phase III studies
demonstrated that add-on therapy with once-daily ... respectively)(3).
Across the clinical studies
conducted, eslicarbazepine acetate ...
More Gene Mutations Linked to Autism Risk
... for their willingness to participate in genetic studies
because family-based studies
have many advantages. We have learned a lot both ... expands the findings of two large autism gene studies
published in April, led by Hakonarson and ...
Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
... of Virginia (U.Va.) to conduct clinical studies
on infant nutrition. U.Va. has been collaborating with PBM during the past few years on studies
regarding PBM's milk, soy, and specialty infant ... Department of Pediatrics and lead researcher on studies
involving PBM formulas, it is very common for ...
Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
... --Integrated human AME studies
comply with recent FDA guidance for earlier ... its integrated radiolabeled clinical pharmacology studies
in compliance with Food and Drug Administration ... our 130th AME study."
The results of AME studies
provide essential information about the ...
Gene Findings Unlocking Reasons for Neuroblastoma Risk
... June 22 /PRNewswire-USNewswire/ -- Two new studies
from The Children's Hospital of Philadelphia ... surprisingly, our genome-wide association studies
found that BARD1 is a susceptibility gene for ... cancer.
The current findings build on 2008 studies
by Maris's lab, one identifying the ALK gene as ...
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
... male and female subjects were included in these studies
and studied initially for either 12 or 24 weeks. ... that results of clinical or pre-clinical studies
indicate that the product candidates are unsafe ... the results of earlier clinical trials and studies
may not be predictive of future results. ...
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
... sperm motility.
Cordex has sponsored studies
at the University of Pennsylvania and the ... human sperm.
Results from these published studies
support earlier observations from a non-Cordex ... the female reproductive tract. Cordex's sponsored studies
have shown that ATP treatment can improve the ...
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
... risk patient subgroups
Additional Clinical studies
Also Highlighted at Pan Pacific Conference
... that an overview of CTI's pixantrone clinical studies
in aggressive and indolent NHL including ...
Review of Pixantrone Clinical studies
in Indolent non-Hodgkin's lymphoma
Alfacell Provides Shareholder Update
... Biotechnology, to conduct a series of animal studies
on immune deficient mice to see what effect ... compelling evidence from numerous preclinical studies
including investigations on animals that Onconase ... We anticipate results shortly.
will be conducted in order to elucidate if ...
New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
... announced today that three new independent studies
demonstrating the clinical accuracy and utility ... are also invasive and costly. Multiple recent studies
have shown that Masimo PVI provides a simple and ... monitoring of fluid responsiveness. The three studies
presented at the ESA reinforce the accuracy of ...
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
... of two randomized, placebo-controlled Phase 3 studies
showed that subcutaneous (SC) injections of ... symptom relief demonstrated in these Phase 3 studies
is encouraging," said Robert J. Spiegel, MD, ... deaths occurred.
The GO-REVEAL and GO-RAISE studies
were supported by Centocor Ortho Biotech Inc. and ...
Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients
... in Copenhagen, Denmark, along with additional studies
that support the use of ACTEMRA as a long-term ... from two ongoing, long-term ACTEMRA extension studies
consisting of patients who had completed one of four 24-week controlled studies
of ACTEMRA as monotherapy or with DMARDs. ...
Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
Advocate Blood Conservation and Appropriate ... pulse oximetry, announced today that two new studies
- one conducted in patients undergoing general ... sepsis, and mortality after surgery.(1,2) These studies
suggest that transfusions and their associated ...
Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
... so called minimal residual disease (MRD). Various studies
have confirmed that ALL patients with MRD ... appeared promising in early research, preclinical studies
or clinical trials do not demonstrate safety ... results from early research, preclinical studies
or clinical trials may not be confirmed upon ...
Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
... International Congress in Paris, France. The studies
were sponsored by Merz Pharmaceuticals, which ... in the near future.
"The results of these studies
reaffirm our beliefs that NT-201 (Xeomin(R); ... or cerebral palsy, warranting additional studies
as a potential treatment option for a wide scope ...
Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL
... preclinical, Phase I and Phase II clinical studies
with pixantrone was reviewed in the May 2009 ... low cardiotoxicity profile in preclinical animal studies
when compared to standard anthracycline drugs.
Five phase I/II studies
in which pixantrone was added to standard ...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
... report by the International Diabetes Federation. studies
have shown that weight loss of 5% to 10% is ... results of clinical trials or preclinical studies
may not be predictive of future results; clinical trials and studies
may not proceed at the time or in the manner ...
Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students
... five young investigators who will conduct their studies
under the supervision of an established lupus ... Gina M. Finzi Fellowship recipients and their studies
Ian Kroll, University of California, ... Down the Barriers , also supports important studies
in areas of research that have been neglected or ...
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
... Endo-Surgery, Inc. today announced that multiple studies
presented at the 2009 Digestive Disease Week ... support in porcine models. One of the studies
concluded that a new adaptable minimally-invasive ... natural orifice surgery and SSL.
The seven studies
presented at DDW, which involved porcine models ...
Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
... Breast Cancer -
- Data in All Three studies
Surpassed Pre-Established Criteria for Expansion ... Recently-reported data highlights from these studies
include the following:
-- Non-Small ... objective of these multi-center, open-label studies
is to assess the overall patient response rate to ...
Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
... insertion of feeding tubes. Published preclinical studies
have demonstrated that, unlike standard ... who have a pathologic CR in most historical studies
have had a major survival advantage over those ... paclitaxel chemotherapy. Preclinical and clinical studies
support that OPAXIO metabolism by lung cancer ...
Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
... analog, which recently began Phase 1 clinical studies
and Racivir, for the treatment of HIV that has ... the risk that the results of previously conducted studies
involving our product candidates will not be repeated or observed in ongoing or future studies
involving our product candidates, the risk that ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... were similar to those observed in previous studies
with CR011-vcMMAE; the most common adverse events ... Officer of CuraGen. "The remainder of these studies
will be used to better understand the breast ... for patients with advanced melanoma is poor, and studies
have shown that the median survival is less than ...
Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
... --Data from Phase 3 REDUCE-1 and REDUCE-2 studies
Demonstrate that Novel Combination Treatment ... and REDUCE-2. The primary objective of these studies
was to evaluate the proportion of patients ... commonly reported adverse events in these two studies
were dyspepsia, nausea, diarrhea, constipation, ...
Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
... associated with brain tumors and from preclinical studies
of XERECEPT in brain tumor models.
NTI sold ... data from the clinical trials or the preclinical studies
and cannot independently corroborate the results ... Usage Compared to Placebo
New Preclinical studies
Indicate XERECEPT(R) May Have Direct Anti-Tumor ...
Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
... in Phase 2. The recent initiation of Phase 1 studies
in multiple myeloma and leukemia will allow us to ... These data and the initiation of additional studies
have added significant value to the program and, ... and multiple mechanisms of action. Preclinical studies
with ENMD-2076 demonstrated significant antitumor ...